Cannabis Watch: Curaleaf shines in falling cannabis sector on news of surprising CVS deal

Cannabis stocks were mostly lower Thursday, with Curaleaf Holdings Inc. a standout after announcing a partnership with drugstore chain CVS Health Corp. on a line of CBD products.

Curaleaf shares CURLF, +14.91% rose 3.3%, after the company said CVS CVS, +1.84% is already selling products including creams, sprays, roll-ons, lotions and salves in eight states.

But CBD, the non-psychoactive ingredient in the cannabis plant, is not actually legal yet. While hemp was fully legalized in the 2018 Farm Bill passed in December, CBD was not included but instead was put under the purview of the U.S.

>>> Original Source <<<